Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Contact your prescriber, GP, or midwife as soon as possible
Side effects, such as nausea or stomach upset, and unknown long-term risks mean its smart to consider the entire health canvas
Key differences at a glance Understanding GLP-1 medications GLP-1 (glucagon-like peptide-1) receptor agonists were originally developed for type 2 diabetes but have revolutionised obesity treatment
225 In addition, MF59 can stimulate IL-4 and STAT6 signal pathways and induce the antibody response
Muscle Preservation Decreased nitrogen wasting and improved organ nitrogen content
Understanding these distinctions, alongside your medical history and comorbidities, enables you and your healthcare provider to select the most suitable option for managing type 2 diabetes or weight
